Related Experiment Video
Updated: Sep 8, 2025

Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
Investigation of Mitochondrial Related Variants in a Cerebral Small Vessel Disease Cohort
P J Dunn1,2, N R Harvey1,2,3, N Maksemous1
1Centre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology (QUT), 60 Musk Ave., Kelvin Grove, Queensland, 4059, Australia.
Abstract:
Monogenic forms of cerebral small vessel disease (CSVD) can be caused by both variants in nuclear DNA and mitochondrial DNA (mtDNA). Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is known to have a phenotype similar to Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy (CADASIL), and can be caused by variants in the mitochondrial genome and in several nuclear-encoded mitochondrial protein (NEMP) genes. The aim of this study was to screen for variants in the mitochondrial genome and NEMP genes in a NOTCH3-negative CADASIL cohort, to identify a potential link between mitochondrial dysfunction and CSVD pathology. Whole exome sequencing was performed for 50 patients with CADASIL-like symptomology on the Ion Torrent system. Mitochondrial sequencing was performed using an in-house designed protocol with sequencing run on the Ion GeneStudio S5 Plus (S5 +). NEMP genes and mitochondrial sequencing data were examined for rare (MAF < 0.001), non-synonymous variants that were predicted to have a deleterious effect on the protein. We identified 29 candidate NEMP variants that had links to either MELAS-, encephalopathy-, or Alzheimer's disease-related phenotypes. Based on these changes, variants affecting POLG, MTO1, LONP1, NDUFAF6, NDUFB3, and TCIRG1 were thought to play a potential role in CSVD pathology in this cohort. Overall, the exploration of the mitochondrial genome identified a potential role for mitochondrial related proteins and mtDNA variants contributing to CSVD pathologies.
Insights
This study investigated mitochondrial DNA and nuclear-encoded mitochondrial protein gene variants in Cerebral Small Vessel Disease (CSVD) patients. Findings suggest mitochondrial dysfunction contributes to CSVD pathology, implicating specific gene variants.
Area of Science:
- Genetics
- Neurology
- Mitochondrial Biology
Background:
- Monogenic cerebral small vessel disease (CSVD) can arise from nuclear or mitochondrial DNA (mtDNA) variants.
- Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) shares phenotypes with Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy (CADASIL).
- Both mtDNA and nuclear-encoded mitochondrial protein (NEMP) genes are implicated in MELAS.
Purpose of the Study:
- To screen for mtDNA and NEMP gene variants in a NOTCH3-negative CADASIL cohort.
- To explore the potential link between mitochondrial dysfunction and CSVD pathology.
- To identify novel genetic contributors to CSVD.
Main Methods:
- Whole exome sequencing of 50 patients with CADASIL-like symptoms.
- Mitochondrial genome sequencing using a custom protocol.
- Analysis of rare, non-synonymous NEMP and mtDNA variants predicted to be deleterious.
Main Results:
- Identified 29 candidate NEMP variants associated with MELAS, encephalopathy, or Alzheimer's disease phenotypes.
- Variants in POLG, MTO1, LONP1, NDUFAF6, NDUFB3, and TCIRG1 were implicated in CSVD pathology.
- Mitochondrial genome exploration revealed potential roles for mtDNA variants and mitochondrial proteins in CSVD.
Conclusions:
- Mitochondrial dysfunction and specific mtDNA variants may contribute to CSVD.
- This study highlights the role of NEMP genes in CSVD pathogenesis.
- Further research into mitochondrial involvement in CSVD is warranted.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023